Equities research analysts forecast that Lannett Co Inc (NYSE:LCI) will report earnings of $0.52 per share for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Lannett Co’s earnings. The highest EPS estimate is $0.52 and the lowest is $0.50. Lannett Co posted earnings of $0.77 per share during the same quarter last year, which would suggest a negative year over year growth rate of 32.5%. The firm is expected to announce its next quarterly earnings report after the market closes on Monday, November 6th.
According to Zacks, analysts expect that Lannett Co will report full-year earnings of $2.66 per share for the current year, with EPS estimates ranging from $2.47 to $2.91. For the next financial year, analysts anticipate that the company will post earnings of $2.83 per share, with EPS estimates ranging from $2.50 to $3.20. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that follow Lannett Co.
Lannett Co (NYSE:LCI) last posted its quarterly earnings results on Wednesday, August 23rd. The company reported $0.40 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.40. The business had revenue of $139.10 million during the quarter, compared to analyst estimates of $139.01 million. Lannett Co had a negative net margin of 0.09% and a positive return on equity of 19.80%. The firm’s revenue was down 17.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 earnings per share.
A number of equities analysts have weighed in on the company. Zacks Investment Research raised Lannett Co from a “sell” rating to a “hold” rating in a research report on Tuesday, October 24th. Deutsche Bank AG reaffirmed a “hold” rating and set a $23.00 price target (up previously from $22.00) on shares of Lannett Co in a research report on Monday, July 17th. BidaskClub downgraded Lannett Co from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. ValuEngine raised Lannett Co from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. Finally, Oppenheimer Holdings Inc. reaffirmed a “hold” rating on shares of Lannett Co in a research report on Wednesday, August 23rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company’s stock. Lannett Co has a consensus rating of “Hold” and an average target price of $21.80.
Shares of Lannett Co (NYSE LCI) traded up 2.44% during trading on Monday, reaching $23.05. 451,098 shares of the company traded hands. Lannett Co has a 12 month low of $14.90 and a 12 month high of $27.90. The stock’s market cap is $859.40 million. The stock’s 50 day moving average price is $20.33 and its 200-day moving average price is $20.15.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Week Herald and is the sole property of of Week Herald. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://weekherald.com/2017/11/15/0-52-earnings-per-share-expected-for-lannett-co-inc-lci-this-quarter.html.
Institutional investors have recently made changes to their positions in the company. KBC Group NV bought a new stake in shares of Lannett Co during the 2nd quarter worth approximately $1,824,000. Swiss National Bank raised its stake in shares of Lannett Co by 3.8% during the 1st quarter. Swiss National Bank now owns 48,800 shares of the company’s stock worth $1,091,000 after purchasing an additional 1,800 shares in the last quarter. Highbridge Capital Management LLC bought a new stake in shares of Lannett Co during the 1st quarter worth approximately $287,000. Oppenheimer & Co. Inc. bought a new stake in shares of Lannett Co during the 2nd quarter worth approximately $271,000. Finally, Schwab Charles Investment Management Inc. raised its stake in shares of Lannett Co by 6.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 153,632 shares of the company’s stock worth $3,135,000 after purchasing an additional 9,005 shares in the last quarter. Institutional investors own 88.23% of the company’s stock.
Lannett Co Company Profile
Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lannett Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Co Inc and related companies with MarketBeat.com's FREE daily email newsletter.